Bloomberg
GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue
Friday, October 30, 2026
Dis-Chem Pharmacies Ltd. reported that dispensary revenue grew in double digits, with increased demand for GLP-1 medicines contributing to the growth. GLP-1 drugs treat diabetes and obesity. The pharmacy chain operates in South Africa.
Original reporting:
